FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
Jun 13, 2025 12:53 PM - Davit Kirakosyan
Adobe Beats Q2 Amid Strong AI Momentum, But Stocks Drops 5%
Adobe (NASDAQ:ADBE) has turned in a stronger-than-expected performance for its fiscal second quarter, prompting the software powerhouse to lift its full-year financial projections. Riding the continued surge in demand for AI-driven creative tools, the company’s core digital media division delivered ...
Jun 13, 2025 12:50 PM - Davit Kirakosyan
RH Soars 22% After Surprise Q1 Profit
RH (NYSE:RH) shares surged more than 22% intra-day today after the upscale furniture brand defied expectations with an unexpected first-quarter profit, signaling resilience amid economic headwinds. The company earned 13 cents per share, surprising analysts who had anticipated a loss of 9 cents per s...
Jun 13, 2025 12:48 PM - Davit Kirakosyan
Diodes Gets Price Target Boost as New Leadership Charts Growth-Focused Course
Benchmark raised Diodes (NASDAQ:DIOD) price target from $55 to $62 while maintaining a Buy rating. The upgrade reflects growing optimism around the company’s evolving strategy under its recently appointed leadership team. Following meetings with CEO Gary Yu and CFO Brett Whitmire, the analysts highl...
Jun 13, 2025 12:45 PM - Davit Kirakosyan
Meta Doubles Down on AI With $14.3B Scale AI Deal, Citi Sees Long-Term Upside
Citi is maintaining its bullish stance on Meta Platforms (NASDAQ:META), reiterating a Buy rating and a $690 price target following the tech giant’s $14.3 billion investment in Scale AI. The deal grants Meta a 49% stake in the artificial intelligence firm, valuing Scale AI at $29 billion based on pro...
Jun 13, 2025 12:43 PM - Davit Kirakosyan
Citi Lowers Rating on Sherwin-Williams Amid Housing Market Headwinds
Sherwin-Williams (NYSE:SHW) saw its rating cut by Citi from Buy to Neutral, with the price target trimmed to $385 from $405, as analysts flagged ongoing challenges in the housing sector that could weigh on near-term performance. As a result, the company’s shares fell over 3% intra-day today. Citi po...
Jun 13, 2025 12:41 PM - Davit Kirakosyan
Paysign Gets Price Target Bump as Plasma Network Expands Sharply
DA Davidson raised its price target on Paysign (NASDAQ:PAYS) to $8 from $7 while reaffirming a Buy rating, following a major boost to the company's plasma donation center footprint. Paysign recently announced the addition of 132 established plasma centers through an expanded partnership with a key p...
Jun 13, 2025 12:00 PM - Stuart Mooney
AIM ImmunoTech Inc. (AMEX:AIM) Strengthens Intellectual Property Portfolio Amid Financial Challenges
AIM ImmunoTech Inc. (AMEX:AIM) is a biotechnology company focused on developing and manufacturing therapeutic products, including their flagship product, Ampligen®. The company operates in a competitive industry, with peers like Moderna and BioNTech. AIM's recent activities include a notable stock p...
